Credo Preps MDx System, Multiplex Respiratory Test for US Launch
/
DateSep 20 2024
NEW YORK – Singapore-based Credo Diagnostics Biomedical is preparing to start US clinical trials for a new near-patient point-of-care molecular diagnostic system and multiplex respiratory... Read More →